结核分枝杆菌与全基因组测序:距离充分发挥其潜力还有多远?
该叙述性综述检索截至2017年5月31日的英文文献,分析全基因组测序(WGS)在结核分枝杆菌(MTB)药物敏感性预测、暴发调查与遗传多样性及研究应用三方面的现状。作者认为WGS已实现许多最初预期,具有高灵敏度与潜力,但解读药敏结果和生物信息学支持等方面仍存重要局限,需谨慎应用。
要点
- WGS已用于MTB诊断、耐药检测和分型,英格兰自2017年起率先在全国范围应用。
- WGS在药敏预测、暴发调查和遗传多样性研究方面已实现许多最初预期。
- 解读WGS数据仍需谨慎,药敏正确解读和生物信息学支持是重要局限。
核心结论
- WGS具有前所未有的灵敏度和能力,有望在近期解决MTB许多未解问题,但解读其数据时仍需注意重要局限。
研究设计与样本
- 叙述性综述,检索MEDLINE、Embase和Scopus中截至2017年5月31日发表的英文原始研究和综述。
主要发现
- 英格兰自2017年起成为全球首个在全国范围使用WGS进行结核病诊断、耐药检测和MTB分型的国家。
- WGS在MTB药物敏感性预测、暴发调查与遗传多样性以及下一代测序研究应用三个主题上已实现许多最初预期。
临床怎么用
- 可将WGS用于MTB的诊断、耐药检测和分型,但解读药敏结果和依赖生物信息学支持时需谨慎。
局限性
- WGS数据解读存在重要局限,涉及药物敏感性的正确解读和所需的生物信息学支持。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nearly two decades after completion of the genome sequence of Mycobacterium tuberculosis (MTB), and with the advent of next generation sequencing technologies (NGS), whole-genome sequencing (WGS) has been applied to a wide range of clinical scenarios. Starting in 2017, England is the first country in the world to pioneer its use on a national scale for the diagnosis of tuberculosis, detection of drug resistance, and typing of MTB. AIMS: This narrative review critically analyses the current applications of WGS for MTB and explains how close we are to realizing its full potential as a diagnostic, epidemiologic, and research tool. SOURCES: We searched for reports (both original articles and reviews) published in English up to 31 May 2017, with combinations of the following keywords: whole-genome sequencing, Mycobacterium, and tuberculosis. MEDLINE, Embase, and Scopus were used as search engines. We included articles that covered different aspects of whole-genome sequencing in relation to MTB. CONTENT: This review focuses on three main themes: the role of WGS for the prediction of drug susceptibility, MTB outbreak investigation and genetic diversity, and research applications of NGS. IMPLICATIONS: Many of the original expectations have been accomplished, and we believe that with its unprecedented sensitivity and power, WGS has the potential to address many unanswered questions in the near future. However, caution is still needed when interpreting WGS data as there are some important limitations to be aware of, from correct interpretation of drug susceptibilities to the bioinformatic support needed.
引用
- Satta G, Lipman M, Smith GP, et al. Mycobacterium tuberculosis and whole-genome sequencing: how close are we to unleashing its full potential? Clin Microbiol Infect. 2017. PMID: 29108952. doi:10.1016/j.cmi.2017.10.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。